ArticleFrontiers in pharmacology2021
Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens.
Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 36 citations in OpenAlex.
- Trial
- Ulcerative colitis (UC) in the elderly: diagnostic and therapeutic considerations.Frontiers in aging · 2026Review
- Polypharmacy as an ordered indicator of therapeutic complexity in a national cardiovascular prevention programme.Frontiers in pharmacology · 2026Article
- Polypill in heart failure: a pathway to simplified treatment and improved adherence and outcomes.Heart failure reviews · 2025Review
- Patterns of Healthcare Use and Disease Burden Among Older Adults in Poland: A Large-Scale Retrospective Study of Primary Care Utilization.Geriatrics (Basel, Switzerland) · 2025Article
- Polypharmacy among adults receiving outpatient care at Kitgum General Hospital, Northern Uganda.BMC primary care · 2025Article
- Polypharmacy Prevalence Among Older Adults Based on the Survey of Health, Ageing and Retirement in Europe: An Update.Journal of clinical medicine · 2025Article
- Operational Definitions of Polypharmacy and Their Association with All-Cause Hospitalization Risk: A Conceptual Framework Using Administrative Databases.Pharmacy (Basel, Switzerland) · 2025Article
- Article
- A Review of Risk Factors for Polypharmacy: Age, Level of Education, and Physician's Attitude.Cureus · 2024Review
- Food Supplements and Their Use in Elderly Subjects-Challenges and Risks in Selected Health Issues: A Narrative Review.Foods (Basel, Switzerland) · 2024Review
- Evaluation of medication safety assessment tools for pharmacist-led medication reviews: the Eastern European pilot project.Frontiers in pharmacology · 2024Article
- Polypharmacology: promises and new drugs in 2022.Pharmacological reports : PR · 2023Review
- Predicting polypharmacy in half a million adults in the Iranian population: comparison of machine learning algorithms.BMC medical informatics and decision making · 2023Article
- Half a Century of Fragmented Research on Deviations from Advised Therapies: Is This a Good Time to Call for Multidisciplinary Medication Adherence Research Centres of Excellence?Pharmaceutics · 2023Article
- Optimizing polypharmacy management in the elderly: a comprehensive European benchmarking survey and the development of an innovative online benchmarking application.Frontiers in pharmacology · 2023Article
- Appropriateness of antimicrobial selection for treatment of pneumonia in selected public hospitals of Eastern Ethiopia: A cross-sectional study.SAGE open medicine · 2023Article
- Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes.Frontiers in pharmacology · 2023Article
- Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study.Frontiers in pharmacology · 2022Article
- Drug-Related Deaths in China: An Analysis of a Spontaneous Reporting System.Frontiers in pharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.